Bayer to divest Diabetes Care to Panasonic

11 June 2015 - Deborah Wilkes

Archived

Bayer has agreed to divest its Diabetes Care business, including the Contour portfolio of blood glucose monitoring meters and strips, to Panasonic Healthcare Holdings in a deal worth €1.02 billion (US$1.15 billion).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: